Palonosetron-Induced Anaphylaxis During General Anesthesia: A Case Report.
- Author:
Hyungjun PARK
1
;
Kyunghwan OH
;
Hoonhee LEE
;
Ji Hyang LEE
;
Sun Myoung KANG
;
So Young PARK
;
Hyouk Soo KWON
;
You Sook CHO
;
Hee Bom MOON
;
Tae Bum KIM
Author Information
- Publication Type:Case Report
- Keywords: Anaphylaxis; drug hypersensitivity; serotonin 5-jydroxytryptamine-3 receptor antagonist; palonosetron
- MeSH: Adult; Anaphylaxis*; Anesthesia, General*; Blood Pressure; Drug Hypersensitivity; Edema; Ephedrine; Exanthema; Granisetron; Hernia, Inguinal; Herniorrhaphy; Humans; Hydrocortisone; Hypersensitivity; Kidney; Male; Ondansetron; Postoperative Nausea and Vomiting; Respiratory Sounds; Skin Tests
- From:Allergy, Asthma & Immunology Research 2017;9(1):92-95
- CountryRepublic of Korea
- Language:English
- Abstract: Palonosetron is a 5-hydroxytryptamine-3 (5-HT-3) receptor antagonist used for preventing postoperative nausea and vomiting. Compared with ondansetron and granisetron, it is a better drug because of prolonged action and minimal side effects. Some adverse effects of palonosetron have been reported. In this report, we describe a 37-year-old male who developed severe hypersensitivity reactions to palonosetron during surgery for kidney donation. His medical history was unremarkable, except for inguinal hernia with herniorrhaphy 8 years ago. The surgery was uneventful until 2 hours 20 minutes. After palonosetron injection, his blood pressure dropped to 80/50 mm Hg, and facial edema, rash, conjunctival swelling, and wheezing developed. The patient was resuscitated by administration of ephedrine, hydrocortisone, and peniramine. Following the surgery, the patient was monitored for 3 days, and there were no subsequent anaphylactic reactions or other complications. The skin test on postoperative day 54 was positive for hypersensitivity to palonosetron. Although palonosetron is known for its safety, other hypersensitivity events have been reported. Ondansetron is another widely used 5-HT-3 antagonist, which has been reported to cause anaphylaxis. Therefore, clinicians should be aware of the possibility of patients experiencing severe adverse reactions to palonosetron.
